{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:44:39Z","timestamp":1793839479396,"version":"4.6.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.phrs.2021.105753","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T11:57:10Z","timestamp":1625227030000},"page":"105753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action"],"prefix":"10.1016","volume":"171","author":[{"given":"Charalampia","family":"Amerikanou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2406-4602","authenticated-orcid":false,"given":"Efstathia","family":"Papada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristea","family":"Gioxari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2431-9369","authenticated-orcid":false,"given":"Ilias","family":"Smyrnioudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatia-Angeliki","family":"Kleftaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1275-3494","authenticated-orcid":false,"given":"Evdokia","family":"Valsamidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajarshi","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8702-2859","authenticated-orcid":false,"given":"Maria Giovanna","family":"Trivella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Milic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Medi\u0107-Stojanoska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Gastaldelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5197-2286","authenticated-orcid":false,"given":"Aimo","family":"Kannt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George V.","family":"Dedoussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriana C.","family":"Kaliora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10159","key":"10.1016\/j.phrs.2021.105753_bib1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Causes of Death Collaborators","year":"2018","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.phrs.2021.105753_bib2","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2021.105753_bib3","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1136\/bmj.m4747","article-title":"Management of non-alcoholic fatty liver disease","volume":"372","author":"Petroni","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2021.105753_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7247238","article-title":"A comprehensive review and update on the pathogenesis of inflammatory bowel disease","volume":"2019","author":"Guan","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"34","key":"10.1016\/j.phrs.2021.105753_bib5","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.3748\/wjg.v22.i34.7727","article-title":"Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: a review article","volume":"22","author":"Chao","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105753_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41419-017-0124-2","article-title":"Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease","volume":"9","author":"Sartini","year":"2018","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.phrs.2021.105753_bib7","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/MIB.0000000000000832","article-title":"Incidence and predictors of nonalcoholic fatty liver disease by serum biomarkers in patients with inflammatory bowel disease","volume":"22","author":"Bessissow","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"issue":"37","key":"10.1016\/j.phrs.2021.105753_bib8","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.3748\/wjg.v25.i37.5676","article-title":"Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: beyond the natural history","volume":"25","author":"Magr\u00ec","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2021.105753_bib9","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.3389\/fimmu.2019.03081","article-title":"Role of host and pathogen-derived MicroRNAs in immune regulation during infectious and inflammatory diseases","volume":"10","author":"Chandan","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105753_bib10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/cells9041041","article-title":"The emerging role of MicroRNAs in NAFLD: highlight of MicroRNA-29a in modulating oxidative stress, inflammation, and beyond","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"issue":"21","key":"10.1016\/j.phrs.2021.105753_bib11","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.3390\/ijms21217893","article-title":"MicroRNA biomarkers in IBD-differential diagnosis and prediction of colitis-associated cancer","volume":"21","author":"James","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105753_bib12","doi-asserted-by":"crossref","first-page":"10606","DOI":"10.1038\/s41598-018-28854-4","article-title":"Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers","volume":"8","author":"L\u00f3pez-Riera","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.phrs.2021.105753_bib13","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3390\/nu9111168","article-title":"Nutrimiromics: role of microRNAs and nutrition in modulating inflammation and chronic diseases","volume":"9","author":"Quintanilha","year":"2017","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.phrs.2021.105753_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/mnfr.201200454","article-title":"miRNAs, polyphenols, and chronic disease","volume":"57","author":"Blad\u00e9","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"issue":"3","key":"10.1016\/j.phrs.2021.105753_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jnutbio.2010.02.008","article-title":"Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155","volume":"22","author":"Boesch-Saadatmandi","year":"2011","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.phrs.2021.105753_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.phrs.2013.03.011","article-title":"One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease","volume":"72","author":"Tom\u00e9-Carneiro","year":"2013","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.phrs.2021.105753_bib17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/ptr.6229","article-title":"Regulation of faecal biomarkers in inflammatory bowel disease patients treated with oral mastiha (Pistacia lentiscus) supplement: a double-blind and placebo-controlled randomised trial","volume":"33","author":"Papada","year":"2019","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2021.105753_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.phymed.2018.08.008","article-title":"Plasma free amino acid profile in quiescent Inflammatory Bowel Disease patients orally administered with Mastiha (Pistacia lentiscus); a randomised clinical trial","volume":"56","author":"Papada","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2021.105753_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202001178","article-title":"Effect of Mastiha supplementation on NAFLD: the MAST4HEALTH Randomised, Controlled Trial","volume":"65","author":"Amerikanou","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105753_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2013.09.002","article-title":"Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease","volume":"60","author":"Banerjee","year":"2014","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105753_bib21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0016-5085(89)90905-0","article-title":"A new measure of health status for clinical trials in inflammatory bowel disease","volume":"96","author":"Guyatt","year":"1989","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.phrs.2021.105753_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000051896","article-title":"Quality of life of Greek patients with inflammatory bowel disease. Validation of the Greek translation of the inflammatory bowel disease questionnaire","volume":"63","author":"Pallis","year":"2001","journal-title":"Digestion"},{"key":"10.1016\/j.phrs.2021.105753_bib23","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/ibd\/izy046","article-title":"Circulating and fecal microRNAs as biomarkers for inflammatory bowel diseases","volume":"24","author":"Sch\u00f6nauen","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"issue":"7","key":"10.1016\/j.phrs.2021.105753_bib24","doi-asserted-by":"crossref","first-page":"41561","DOI":"10.1371\/journal.pone.0041561","article-title":"Comparing the MicroRNA spectrum between serum and plasma","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.phrs.2021.105753_bib25","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.1880","article-title":"The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities","volume":"14","author":"Bonci","year":"2008","journal-title":"Nat. Med."},{"issue":"39","key":"10.1016\/j.phrs.2021.105753_bib26","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2 [published correction appears in Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2464]","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2021.105753_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.01.044","article-title":"The role of microRNA-16 in the pathogenesis of autoimmune diseases: a comprehensive review","volume":"112","author":"Yan","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.phrs.2021.105753_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.phrs.2021.105753_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3892\/br.2016.747","article-title":"Emerging role of microRNA-21 in cancer","volume":"5","author":"Feng","year":"2016","journal-title":"Biomed. Rep."},{"issue":"6","key":"10.1016\/j.phrs.2021.105753_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbadis.2009.02.013","article-title":"miR-155 gene: a typical multifunctional microRNA","volume":"1792","author":"Faraoni","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2021.105753_bib31","doi-asserted-by":"crossref","first-page":"35316","DOI":"10.1038\/srep35316","article-title":"Role of Mir-155 in controlling HIF-1\u03b1 level and promoting endothelial cell maturation","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.phrs.2021.105753_bib32","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3892\/ijmm.2016.2497","article-title":"MicroRNA-16 suppresses the activation of inflammatory macrophages in atherosclerosis by targeting PDCD4","volume":"37","author":"Liang","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.phrs.2021.105753_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biochi.2015.10.004","article-title":"MicroRNA-16 modulates macrophage polarization leading to improved insulin sensitivity in myoblasts","volume":"119","author":"Talari","year":"2015","journal-title":"Biochimie"},{"issue":"31","key":"10.1016\/j.phrs.2021.105753_bib34","doi-asserted-by":"crossref","first-page":"E2110","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2021.105753_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/JLB.3MIR1117-459R","article-title":"miRNA regulation of innate immunity","author":"Momen-Heravi","year":"2018","journal-title":"J. Leukoc. Biol."},{"issue":"29","key":"10.1016\/j.phrs.2021.105753_bib36","doi-asserted-by":"crossref","first-page":"26971","DOI":"10.18632\/oncotarget.4699","article-title":"Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients","volume":"6","author":"Shi","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.phrs.2021.105753_bib37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ni.2576","article-title":"The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling","volume":"14","author":"Gracias","year":"2013","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105753_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2043-9113-3-17","article-title":"The multiple roles of microRNA-155 in oncogenesis","volume":"3","author":"Higgs","year":"2013","journal-title":"J. Clin. Bioinform."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105753_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2013.09.019","article-title":"MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"266","author":"Zhang","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2021.105753_bib40","doi-asserted-by":"crossref","first-page":"23937","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"Cermelli","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.phrs.2021.105753_bib41","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3390\/ijms18071534","article-title":"A nutrigenomic approach to non-alcoholic fatty liver disease","volume":"18","author":"Dongiovanni","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105753_bib42","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1186\/s12885-019-5951-3","article-title":"microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.phrs.2021.105753_bib43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/hep.29833","article-title":"Expression of microRNA-155 in inflammatory cells modulates liver injury","volume":"68","author":"Blaya","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2021.105753_bib44","article-title":"Role of noncoding RNA in development of nonalcoholic fatty liver disease","volume":"2019","author":"Huang","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"10.1016\/j.phrs.2021.105753_bib45","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1159\/000447917","article-title":"Decreased MiR-155 level in the peripheral blood of non-alcoholic fatty liver disease patients may serve as a biomarker and may influence LXR activity","volume":"39","author":"Wang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"9","key":"10.1016\/j.phrs.2021.105753_bib46","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.crohns.2012.02.006","article-title":"Circulating MicroRNA in inflammatory bowel disease","volume":"6","author":"Paraskevi","year":"2012","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.phrs.2021.105753_bib47","doi-asserted-by":"crossref","first-page":"30824","DOI":"10.1038\/srep30824","article-title":"MicroRNA-16 is putatively involved in the NF-\u03baB pathway regulation in ulcerative colitis through adenosine A2a receptor (A2aAR) mRNA targeting","volume":"6","author":"Tian","year":"2016","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.phrs.2021.105753_bib48","doi-asserted-by":"crossref","first-page":"19693","DOI":"10.1097\/MD.0000000000019693","article-title":"Aberrant expression of miR-21 in patients with inflammatory bowel disease: a protocol for systematic review and meta analysis","volume":"99","author":"Yan","year":"2020","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.phrs.2021.105753_bib49","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.crohns.2011.05.007","article-title":"Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease","volume":"5","author":"Archanioti","year":"2011","journal-title":"J. Crohns Colitis"},{"issue":"6","key":"10.1016\/j.phrs.2021.105753_bib50","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3748\/wjg.v23.i6.976","article-title":"MicroRNA-155 promotes the pathogenesis of experimental colitis by repressing SHIP-1 expression","volume":"23","author":"Lu","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105753_bib51","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/imm.12328","article-title":"miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1\/type 17 responses","volume":"143","author":"Singh","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2021.105753_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41392-018-0006-9","article-title":"miRNAs reshape immunity and inflammatory responses in bacterial infection","volume":"3","author":"Zhou","year":"2018","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.phrs.2021.105753_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104892","article-title":"Genetics and epigenetics of IBD","volume":"159","author":"Annese","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.phrs.2021.105753_bib54","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/ijms21062061","article-title":"PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null mice","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105753_bib55","doi-asserted-by":"crossref","first-page":"10606","DOI":"10.1038\/s41598-018-28854-4","article-title":"Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers","volume":"8","author":"L\u00f3pez-Riera","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.phrs.2021.105753_bib56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/jir.2018.0155","article-title":"MicroRNA-155: a master regulator of inflammation","volume":"39","author":"Mahesh","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"issue":"6","key":"10.1016\/j.phrs.2021.105753_bib57","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2016.02.039","article-title":"Tiny RNA with great effects: miR-155 in alcoholic liver disease","volume":"64","author":"Hartmann","year":"2016","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.phrs.2021.105753_bib58","doi-asserted-by":"crossref","first-page":"72324","DOI":"10.1371\/journal.pone.0072324","article-title":"MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice","volume":"8","author":"Miller","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.phrs.2021.105753_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129251","article-title":"MicroRNA-155 deficiency attenuates liver steatosis and fibrosis without reducing inflammation in a mouse model of Steatohepatitis","volume":"10","author":"Csak","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2021.105753_bib60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5114\/ceh.2017.68466","article-title":"The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease","volume":"3","author":"\u015awiderska","year":"2017","journal-title":"Clin. Exp. Hepatol."},{"issue":"20","key":"10.1016\/j.phrs.2021.105753_bib61","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.3390\/ijms20205045","article-title":"Liver X receptors regulate cholesterol metabolism and immunity in hepatic nonparenchymal cells","volume":"20","author":"Endo-Umeda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2021.105753_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108778","article-title":"Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease","volume":"113","author":"Ni","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"18","key":"10.1016\/j.phrs.2021.105753_bib63","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.3390\/ijms20184522","article-title":"Oxysterols in autoimmunity","volume":"20","author":"Duc","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2021.105753_bib64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.intimp.2018.11.045","article-title":"Suppression of miR-21 and miR-155 of macrophage by cinnamaldehyde ameliorates ulcerative colitis","volume":"67","author":"Qu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2021.105753_bib65","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.intimp.2018.09.007","article-title":"MiR-155 inhibition ameliorates 2, 4, 6-Trinitrobenzenesulfonic acid (TNBS)-induced experimental colitis in rat via influencing the differentiation of Th17 cells by Jarid2","volume":"64","author":"Liu","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2021.105753_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111535","article-title":"Linking the IL-17A immune response with NMR-based faecal metabolic profile in IBD patients treated with Mastiha","volume":"138","author":"Amerikanou","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.phrs.2021.105753_bib67","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/antiox8070208","article-title":"Antioxidant and anti-inflammatory properties of Mastiha: a review of preclinical and clinical studies","volume":"8","author":"Papada","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.phrs.2021.105753_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112485","article-title":"Traditional uses, phytochemistry and pharmacology of Chios mastic gum (Pistacia lentiscus var. Chia, Anacardiaceae): a review","volume":"254","author":"Pachi","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105753_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jep.2006.10.031","article-title":"Chios mastic gum modulates serum biochemical parameters in a human population","volume":"111","author":"Triantafyllou","year":"2007","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105753_bib70","article-title":"Bioavailability of terpenes and postprandial effect on human antioxidant potential. An open-label study in healthy subjects","volume":"62","author":"Papada","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.phrs.2021.105753_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2020.112596","article-title":"Tirucallane triterpenoids from the mastic (Pistacia lentiscus) and their anti-inflammatory and cytotoxic activities","volume":"182","author":"Liu","year":"2021","journal-title":"Phytochemistry"},{"issue":"5","key":"10.1016\/j.phrs.2021.105753_bib72","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3181\/0811-RM-338","article-title":"Chios mastic gum extract and isolated phytosterol tirucallol exhibit anti-inflammatory activity in human aortic endothelial cells","volume":"234","author":"Loizou","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.phrs.2021.105753_bib73","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1089\/jmf.2012.0018","article-title":"Chios mastic fractions in experimental colitis: implication of the nuclear factor kappab pathway in cultured ht29 cells","volume":"15","author":"Papalois","year":"2012","journal-title":"J. Med. Food"},{"key":"10.1016\/j.phrs.2021.105753_bib74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/B978-0-12-800096-0.00006-8","article-title":"MicroRNA in gastrointestinal cancer: a step closer to reality","volume":"62","author":"Link","year":"2013","journal-title":"Adv. Clin. Chem."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821003376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821003376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:23:39Z","timestamp":1760912619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821003376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":74,"alternative-id":["S1043661821003376"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105753","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105753"}}